Writing About Health Responsibly: A Practical Source-Checking Guide for Authors and Editors

Health writing can look deceptively similar to ordinary explanatory writing. The sentences may be simple, the audience may be general, and the article may contain no diagnosis or treatment plan. Yet the editorial burden is higher because a reader can act on an inaccurate claim. Source checking therefore needs to happen before the copy is polished, not after.

A useful rule is to ask what kind of evidence the sentence actually needs. A definition may be supported by an authoritative reference source. A claim about an intervention’s effect may require primary research or a high-quality synthesis. A drug-safety statement may require a regulator, official label or current clinical guidance. A testimonial or another article repeating the same claim is rarely enough.

Start by separating claim types

Editors can make verification faster by marking claims as they read. Is the sentence describing a mechanism, association, treatment effect, risk, prevalence, regulatory status or practical recommendation? Different claim types call for different evidence.

For example, “people who did X had a lower rate of Y” may describe an association in an observational study. Rewriting it as “X prevents Y” changes the causal meaning. The editor’s job is not merely to preserve the number; it is to preserve what the study design can support.

Prefer primary sources for specific research claims

The ICMJE recommendations on manuscript preparation advise authors to provide direct references to original research sources whenever possible and to verify that references support the associated statement. That is an excellent rule for health publishing beyond academic journals.

Reviews and institutional summaries can be useful for orientation, but if an article gives a precise effect estimate, sample size or study conclusion, open the original paper. Check who was studied, what outcome was measured, how long follow-up lasted and whether the result being quoted was a primary or secondary endpoint.

Do not turn association into causation

Observational research can reveal important associations, but confounding and selection effects may remain. Randomised trials can support stronger causal inference in suitable contexts, but they also have limits. Laboratory studies and animal studies answer still different questions.

An editor should make the study design visible in the language: “was associated with,” “participants assigned to,” “in a laboratory model,” or “in mice” prevents the reader from silently upgrading the evidence.

Report risk in a way readers can interpret

Relative effects can sound dramatic without the baseline risk. If a result is described as a percentage reduction or increase, check whether an absolute figure can also be given from the same source. State the time period and population. Avoid presenting a subgroup result as if it applied to everyone.

Editors should also distinguish statistical significance from practical or clinical importance. ICMJE specifically advises authors to distinguish clinical and statistical significance. A small effect can be statistically detectable without being important to a patient, while an uncertain estimate may still be clinically relevant enough to justify further study.

Check terminology before simplifying it

Plain language should reduce unnecessary complexity, not alter the concept. “Adverse event,” “side effect,” “contraindication,” “interaction,” “approved use” and “off-label use” are not interchangeable. If a technical term must be simplified, verify that the replacement keeps the same scope.

This is especially important when a writer paraphrases several sources. Two papers may use the same everyday word differently. Keep a short terminology note during editing so the article does not shift meaning from section to section.

Disclose conflicts and commercial context

Funding or commercial relationships do not automatically invalidate research, but readers need relevant context. The ICMJE conflict-of-interest guidance emphasises transparent disclosure of relationships and activities so readers can make their own judgments.

Editors should look for study funding, author disclosures, sponsor involvement and commercial links in the article being published. A health piece should not present promotional copy as independent evidence.

Check whether guidance is still current

A source can be authoritative and outdated. Guidance may be revised; drug warnings and regulatory status can change. Record the date you checked each source and prefer the current version of an official page. When old guidance is historically important, label it as historical rather than silently using it as current advice.

Drug information needs a specialist verification path

Medication writing deserves an extra check because brand names, active ingredients, strengths, species and regulatory status can be confused. For veterinary content, the FDA’s animal-drug FAQ illustrates why product identity and animal context matter.

Specialist references can also be useful when their scope is explicit. For example, a specialist pet-medication reference with explicit scope limits explains that its notes are for orientation and question preparation, not veterinary diagnosis or dosing. That boundary is editorially valuable: a source should tell the reader what it cannot establish as clearly as what it can.

Create a correction path before you need it

Health information will sometimes need correction because evidence, guidance or an editorial fact changes. A publisher should know who receives correction requests, how the original text is amended and whether readers can see that a material change occurred.

The ICMJE correction and version-control recommendations call for transparent correction notices and updated versions when factual errors are identified. A web publisher may use a simpler implementation, but the principle is the same: do not silently erase a material error and pretend it was never published.

A practical editorial checklist

Before publication, the author or editor should be able to answer each of these questions:

• Authorship: Is the writer or reviewer identifiable, and are relevant credentials or roles stated accurately?
• Claim type: Have association, causation, mechanism, risk and recommendation been kept distinct?
• Evidence: Does each important claim have a source appropriate to the claim?
• Primary source: Have precise study claims been checked against the original research where practical?
• Population: Does the article say who was studied instead of generalising automatically?
• Numbers: Are denominators, time periods and absolute context supplied where needed?
• Terminology: Have technical terms been simplified without changing their meaning?
• Conflicts: Are funding, sponsorship and relevant commercial relationships visible?
• Currency: Were guidance, labels and regulatory pages checked for current status?
• Drug identity: Are active ingredient, product, route or species details verified rather than guessed?
• Scope: Does educational content avoid becoming an individual diagnosis or treatment instruction?
• Links: Do citations open, and do they support the sentence they are attached to?
• Corrections: Is there a practical way to update a material error after publication?

Editing for trust means preserving limits

Responsible health writing is not created by adding more citations at the end. It comes from choosing evidence that matches the claim, keeping study design and uncertainty visible, separating education from individual medical decisions, and making corrections when necessary. Publishers that already provide resources for authors and editors and research and publishing resources can treat source checking as part of the editorial workflow rather than a final compliance task.

The strongest health article does not sound more certain than the evidence. It gives readers enough context to understand what is known, what is uncertain, and which questions belong with a qualified professional rather than the page itself.